Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H8N4O3 |
| Molecular Weight | 196.1634 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(=O)NC2=C1C(=O)N(C)C(=O)N2
InChI
InChIKey=NOFNCLGCUJJPKU-UHFFFAOYSA-N
InChI=1S/C7H8N4O3/c1-10-3-4(8-6(10)13)9-7(14)11(2)5(3)12/h1-2H3,(H,8,13)(H,9,14)
| Molecular Formula | C7H8N4O3 |
| Molecular Weight | 196.1634 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers. | 2010-06 |
|
| Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers. | 2009-08 |
|
| CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives. | 2008-05 |
|
| Growth hormone does not alter CYP2A6 activity in growth hormone-deficient children. | 2008-01 |
|
| In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios. | 2007-02 |
|
| Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay. | 2007-02 |
|
| Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice. | 2007 |
|
| Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls. | 2006-12 |
|
| [Determination of the activity of cytochrome P-450 CYP2A6 by HPLC method with caffeine as metabolizing probe]. | 2006-03 |
|
| Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry. | 2005-03 |
|
| Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples. | 2004-10 |
|
| Catabolism of caffeine in plants and microorganisms. | 2004-05-01 |
|
| Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study. | 2004 |
|
| Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug. | 2003-02 |
|
| Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer. | 2002-12-27 |
|
| A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test. | 2002-08 |
|
| Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction. | 2002-08 |
|
| CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. | 2002-04 |
|
| Urinary biomarkers for assessing dietary exposure to caffeine. | 2001-12 |
|
| Use of novel solid-phase extraction sorbent materials for high-performance liquid chromatography quantitation of caffeine metabolism products methylxanthines and methyluric acids in samples of biological origin. | 2001-08-15 |
|
| The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans. | 2001-08 |
|
| Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment. | 2001-05-05 |
|
| Caffeine metabolism before and after liver transplantation. | 2001-02 |
|
| Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis. | 2001-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:39:49 GMT 2025
by
admin
on
Mon Mar 31 19:39:49 GMT 2025
|
| Record UNII |
Z633Z7KAJU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Z633Z7KAJU
Created by
admin on Mon Mar 31 19:39:49 GMT 2025 , Edited by admin on Mon Mar 31 19:39:49 GMT 2025
|
PRIMARY | |||
|
DTXSID30187499
Created by
admin on Mon Mar 31 19:39:49 GMT 2025 , Edited by admin on Mon Mar 31 19:39:49 GMT 2025
|
PRIMARY | |||
|
251-706-2
Created by
admin on Mon Mar 31 19:39:49 GMT 2025 , Edited by admin on Mon Mar 31 19:39:49 GMT 2025
|
PRIMARY | |||
|
91611
Created by
admin on Mon Mar 31 19:39:49 GMT 2025 , Edited by admin on Mon Mar 31 19:39:49 GMT 2025
|
PRIMARY | |||
|
33868-03-0
Created by
admin on Mon Mar 31 19:39:49 GMT 2025 , Edited by admin on Mon Mar 31 19:39:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
URINE
|